Clinical Trial Update: The Expression of Serum Angiogenesis Marker in Patients Presenting With Hemoptysis

View source ↗

Summary

This is a completed clinical trial from Samsung Medical Center investigating serum angiogenesis marker expression in patients with hemoptysis, with no treatment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemoptysis
• Inflammatory Lung Diseases

Snippet

Sponsor: Samsung Medical Center | Conditions: Inflammatory Lung Diseases, Hemoptysis | Status: COMPLETED